Trulieve Cannabis (TRLV) Payables (2020 - 2026)

Trulieve Cannabis has reported Payables for 7 years, with the latest figure at $65.7 million in Q2 2026.

• On a quarterly basis, Payables fell 20.59% year-over-year to $65.7 million in Q2 2026; TTM through Jun 2026 was $65.7 million, a 20.59% decrease from a year earlier, with the FY2025 full-year figure at $86.7 million, down 10.99% from the prior year.
• Payables was $65.7 million for Q2 2026 at Trulieve Cannabis, down from $83.1 million in the prior quarter.
• The five-year high for Payables was $119.3 million in Q1 2022, with the low at $65.7 million in Q2 2026.
• Average Payables over 5 years is $91.2 million, with a median of $91.8 million recorded in 2022.
• The sharpest annual moves came in 2022 and 2026: Payables soared 170.88% in 2022, then slipped 20.59% in 2026.
• Over 5 years, Payables stood at $94.5 million in 2022, then fell by 8.0% to $86.9 million in 2023, then advanced by 12.11% to $97.4 million in 2024, then decreased by 10.99% to $86.7 million in 2025, then retreated by 24.28% to $65.7 million in 2026.
• The last three Payables figures came in at $65.7 million (Q2 2026), $83.1 million (Q1 2026), and $86.7 million (Q4 2025), per Business Quant data.